Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases
Loading...
Files
Accepted version
Additional file: Graphical abstract
Date
2019-01-16
Authors
Balzarini, Jan
Ford, Alan
Maguire, Nuala M.
John, Jubi
Das, Kalyan
Arnold, Eddy
Dehaen, Wim
Maguire, Anita R.
Journal Title
Journal ISSN
Volume Title
Publisher
Future Science
Published Version
Abstract
Acyclic nucleoside phosphonates represent a well-defined class of clinically used nucleoside analogs. All acyclic nucleoside phosphonates need intracellular phosphorylation before they can bind viral DNA polymerases. Recently, a novel class of alpha-carboxynucleoside phosphonates have been designed to mimic the natural 2′-deoxynucleotide 5′-triphosphate substrates of DNA polymerases. They contain a carboxyl group in the phosphonate moiety linked to the nucleobase through a cyclic or acyclic bridge. Alpha-carboxynucleoside phosphonates act as viral DNA polymerase inhibitors without any prior requirement of metabolic conversion. Selective inhibitory activity against retroviral reverse transcriptase and herpesvirus DNA polymerases have been demonstrated. These compounds have a unique mechanism of inhibition of viral DNA polymerases, and provide possibilities for further modifications to optimize and fine tune their antiviral DNA polymerase spectrum.
Description
Keywords
a-carboxynucleoside phosphonate (a-CNP) , Acyclic nucleoside phosphonate (ANP) , Chemotherapeutics , Herpes viruses , HIV , Nucleoside-analog inhibitor , Reverse transcriptase (RT) , Viral DNA polymerase
Citation
Balzarini, J., Ford, A., Maguire, N. M., John, J., Das, K., Arnold, E., Dehaen, W. and Maguire, A. (2019) 'Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases', Future Medicinal Chemistry, 11(2), pp. 137-154. doi: 10.4155/fmc-2018-0324
Link to publisher’s version
Copyright
© 2019 Future Science Group